When did Agios Pharmaceuticals report Q4 2024 earnings?

Agios Pharmaceuticals (AGIO) reported Q4 2024 earnings on February 13, 2025 before market open.

What were Agios Pharmaceuticals's Q4 2024 revenue and EPS?

Agios Pharmaceuticals reported revenue of $10.7M and eps of $-1.74 for Q4 2024.

Did Agios Pharmaceuticals beat estimates in Q4 2024?

Revenue beat the consensus estimate of $9.3M by $1.4M. EPS missed the consensus estimate of $-1.69 by $0.05.

Where can I find Agios Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001439222-25-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.

Agios Pharmaceuticals AGIO Q4 2024 Annual earnings

Reported February 13, 2025 · Before market open

Revenue$10.7MBeat by $1.4M

EPS-$1.74Miss by $0.05

Revenue estimate$9.3M

EPS estimate-$1.69

Next report

Jul 30, 2026 (Today)

Revenue estimate$26.4M

EPS estimate-$1.65

Financials

Q4 2024

Income statement

See full

Revenue$10.7M+51.1%

Gross profit$9.5M+45.3%

Operating income-$125.0M-17.7%

Balance sheet

See full

Cash & equivalents$76.2M-13.6%

Total debt$57.0M-20.8%

Total equity$1.5B+90.0%

Total assets$1.7B+77.5%

Cash flow

See full

Operating cash flow-$133.2M-83.7%

CapEx$967.0K+313%

Free cash flow-$134.1M-84.4%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.87B+50.6%

Enterprise value$1.85B+51.0%

P/S51.3×+4.9×

Profitability

See full

Gross margin88.6%-0.7pp

Operating margin-1,166.5%-195pp

FCF margin-1,072.7%-32.6pp

Returns & leverage

See full

Debt / equity0×-0.1×

Current ratio11.9×-0.4×

Versus estimates

Revenue

Q1 2026$20.7MBeat by $7.4M Q4 2025$20.0MBeat by $7.9M Q3 2025$12.9MBeat by $1.2M Q2 2025$12.5MBeat by $2.2M Q1 2025$8.7MMiss by $1.3M

Q4 2024$10.7MBeat by $1.4M

Diluted EPS

Q1 2026-$1.69Beat by $0.12 Q4 2025-$1.85Beat by $0.12 Q3 2025-$1.78Beat by $0.15 Q2 2025-$1.93Miss by $0.19 Q1 2025-$1.55Beat by $0.25

Q4 2024-$1.74Miss by $0.05

Ask the moment Agios Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Agios Pharmaceuticals report Q4 2024 earnings?: Agios Pharmaceuticals (AGIO) reported Q4 2024 earnings on February 13, 2025 before market open.
What were Agios Pharmaceuticals's Q4 2024 revenue and EPS?: Agios Pharmaceuticals reported revenue of $10.7M and eps of $-1.74 for Q4 2024.
Did Agios Pharmaceuticals beat estimates in Q4 2024?: Revenue beat the consensus estimate of $9.3M by $1.4M. EPS missed the consensus estimate of $-1.69 by $0.05.
Where can I find Agios Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001439222-25-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.